Comprehensive molecular characterization of urothelial bladder carcinoma by The Cancer Genome Atlas (TCGA) led to the identification of FGFR3-TACC3 fusions as recurrent in-frame activating translocations [39]. Here, FGFR3 is linked to bladder transitional cell carcinoma.